Mild Tachycardia In some cases, semaglutide may cause a slight increase in heart rate, a condition known as tachycardia
In March 2025, Novo Nordisk CEO Lars Fruergaard Jrgensen told Bloomberg that he expected to see some short-term impact from the tariffs
Similar estimates were obtained in other studies, although according to the LIPIDOGRAM study, which enrolled nearly 34,000 patients, the estimated prevalence may be even higher [278, 280]
Therefore, brands seek solutions to reduce sugar without the hassle of sourcing new ingredients or worrying about their regulatory approvals
The weight loss effects of semaglutide occur through two primary mechanisms: First, it slows gastric emptying, sending signals to the brain to prompt earlier satiety, thus naturally decreasing food consumption